EICHOR
● Completed
A Clinical Study of the V116 Vaccine for Children and Teenagers (V116-013)
Condition: Pneumococcal Infection · Sponsor: Merck Sharp & Dohme LLC
About this study
The purpose of this study is to evaluate the safety, tolerability, and immunogenicity of V116 compared to PPSV23 in children and teenagers 2 through 17 years of age, who had completed routine pneumococcal vaccine as infants/toddlers. Researchers want to learn if V116 is as good as, or is better than the PPSV23 vaccine in terms of the antibody immune response. V116 and PPSV23 will be studied in children and teenagers who have a higher risk of getting pneumococcal disease (PD).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (92)
| Central Research Associates ( Site 0145) | Birmingham, Alabama, United States | — |
| Velocity Clinical Research, Phoenix ( Site 0122) | Phoenix, Arizona, United States | — |
| Madera Family Medical Group ( Site 0120) | Madera, California, United States | — |
| Optumcare Colorado Springs, LLC ( Site 0113) | Colorado Springs, Colorado, United States | — |
| Accel Research Sites Network- Nona Pediatric Center ( Site 0109) | Orlando, Florida, United States | — |
| University of South Florida-Department of Pediatrics ( Site 0110) | Tampa, Florida, United States | — |
| Velocity Clinical Research at Primary Pediatrics, Macon ( Site 0128) | Macon, Georgia, United States | — |
| Bingham Memorial Hospital ( Site 0149) | Blackfoot, Idaho, United States | — |
| Clinical Research Prime ( Site 0105) | Idaho Falls, Idaho, United States | — |
| Clinical Research Prime Rexburg ( Site 0104) | Rexburg, Idaho, United States | — |
| University of Louisville, Norton Children's Research Institute ( Site 0148) | Louisville, Kentucky, United States | — |
| Velocity Clinical Research, Lafayette ( Site 0103) | Lafayette, Louisiana, United States | — |
+ 80 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06177912